首页 | 本学科首页   官方微博 | 高级检索  
     

肾移植术后免疫抑制剂应用的策略
引用本文:曾甫清,王振迪. 肾移植术后免疫抑制剂应用的策略[J]. 临床泌尿外科杂志, 2005, 20(10): 585-587
作者姓名:曾甫清  王振迪
作者单位:华中科技大学协和医院泌尿外科,武汉,430022;华中科技大学协和医院泌尿外科,武汉,430022
摘    要:肾移植虽已取得长足进步,患者的预后也得到了一定程度的改观,但现今患者仍然需要长期服用免疫抑制剂.肾移植术后的诸多并发症当中,大多数与免疫抑制剂有关,严重影响了移植肾的长期存活.因此,如何调整免疫抑制方案,使其达到低毒化、个体化,成为目前移植工作者急需解决的问题.

关 键 词:肾移植  排斥反应  免疫抑制药
文章编号:1001-1420(2005)10-0585-03
收稿时间:2005-05-23
修稿时间:2005-05-23

Strategies for immunosuppressive agents following kidney transplantation
ZENG Fuqing,WANG Zhendi. Strategies for immunosuppressive agents following kidney transplantation[J]. Journal of Clinical Urology, 2005, 20(10): 585-587
Authors:ZENG Fuqing  WANG Zhendi
Affiliation:1.Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Wuhan,430022, China
Abstract:The outcomes after kidney tran.splantation have continued to improve, hut patients require long term chronic immunosuppression. Immunosuppressive agents remain the cause of most complications following kidney transplantation, which have an adverse effect on long term graft survival. Tterefore. it is urgent for trans plant workers to adjust the strategies and find a low toxicity and individualized immunosuppressive protocol.
Keywords:Kidney transplantation   Rejection   Immunosuppressive agents
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号